Publications Database

Handen B. L. , Johnson C. R. , Lubetsky M. J. (2000)

Efficacy of methylphenidate among children with autism and symptoms of attention-deficit hyperactivity disorder.

Journal of Autism and Developmental Disorders

30(3), pp. 245-255

Read Abstract (New Window)

Handen B. L. , Sahl R. , Hardan A. Y. (2008)

Guanfacine in children with autism and/or intellectual disabilities.

Journal of Developmental and Behavioral Pediatrics

29(4), pp. 303-308

Read Abstract (New Window)

Handen B. L. , Taylor J. , Tumuluru R. V. (2011)

Psychopharmacological treatment of ADHD symptoms in children with autism spectrum disorder.

International Journal of Adolescent Medicine and Health

Read Abstract (New Window)

Handen B. L. et al. (2011)

Safety and efficacy of donepezil in children and adolescents with autism: neuropsychological measures.

Journal of Child and Adolescent Psychopharmacology

February, 21(1), pp. 43-50

Read Abstract (New Window) Read Full (New Window)

Handen B. L. , Hofkosh D. (2005)

Secretin in children with autistic disorder: A double-blind, placebo-controlled trial.

Journal of Developmental and Physical Disabilities

June, 17(2), pp. 95-106.

Read Abstract (New Window)

Hardan A. Y. , Handen B. L. (2002)

A retrospective open trial of adjunctive donepezil in children and adolescents with autistic disorder.

Journal of Child and Adolescent Psychopharmacology

12(3), pp. 237-24

Read Abstract (New Window)

Hardan A. Y. , Jou R. , Handen B. L. (2005)

Retrospective study of quetiapine in children and adolescents with pervasive developmental disorders

Journal of Autism and Developmental Disorders

35 pp. 387-391

Read Abstract (New Window)

Johnson C. R. et al. (2011)

Effects of gluten free / casein free diet in young children with autism: A pilot study

Journal of Developmental and Physical Disabilities

23(3), pp. 213-225.

Read Abstract (New Window)

Johnson C. R. et al. (2010)

Polyunsaturated fatty acid supplementation in young children with autism.

Journal of Developmental and Physical Disabilities

22(1), pp. 1-10.

Read Abstract (New Window)

Jou R. , Handen B. L. , Hardan A. Y. (2005)

Retrospective assessment of atomoxetine in children and adolescents with pervasive developmental disorders.

Journal of Child and Adolescent Psychopharmacology

15(2), pp. 325-330

Read Abstract (New Window)

King B. H. et al. (2001)

Double-blind, placebo-controlled study of amantadine hydrochloride in the treatment of children with autistic disorder.

Journal of the American Academy of Child and Adolescent Psychiatry

40(6), pp. 658-665

Read Abstract (New Window)

Kolmen B. K. et al. (1995)

Naltrexone in young autistic children: a double-blind, placebo-controlled crossover study.

Journal of the American Academy of Child and Adolescent Psychiatry

34(2), pp. 223-231

Read Abstract (New Window)

Kolmen B. K. et al. (1997)

Naltrexone in young autistic children: replication study and learning measures.

Journal of the American Academy of Child and Adolescent Psychiatry

36(11), pp. 1570-1578

Read Abstract (New Window)

Lecavalier L. et al. (2014)

Measuring anxiety as a treatment endpoint in youth with autism spectrum disorder.

Journal of Autism and Developmental Disorders

May, 44(5), pp. 1128-1143.

Read Abstract (New Window) Read Full (New Window)

Lecavalier L. et al.

Parent stress in a randomized clinical trial of atomoxetine and parent training for children with autism spectrum disorder.

Journal of Autism and Developmental Disorders

Read Abstract (New Window)

Lubetsky M. J. et al. (2014)

Systems of care for individuals with autism spectrum disorder and serious behavioral disturbance through the lifespan.

Child and Adolescent Psychiatric Clinics of North America

January, 23(1), pp. 97-110.

Mahajan R. et al. (2012)

Clinical practice pathways for evaluation and medication choice for attention-deficit/hyperactivity disorder symptoms in autism spectrum disorders.

Pediatrics

130 S125-138

Read Abstract (New Window) Read Full (New Window)

Scahill L. et al. (2012)

Effects of risperidone and parent training on adaptive functioning in children with pervasive developmental disorders and serious behavioral problems.

Journal of the American Academy of Child and Adolescent Psychiatry

51(2), pp. 136-146

Read Abstract (New Window)

Smith T. et al. (2016)

Atomoxetine and parent training for children with autism and attention-deficit-hyperactivity disorder: A 24-week extension study.

Journal of the Canadian Academy of Child and Adolescent Psychiatry

October, 55(10),

Read Abstract (New Window)

Varni J. W. et al. (2012)

Effect of aripiprazole 2 to 15 mg/d on health-related quality of life in the treatment of irritability associated with autistic disorder in children: A post hoc analysis of two controlled trials.

Clinical Therapeutics

34(4), pp. 980-992.

Read Abstract (New Window)